Cell Signaling Technology

Product Pathways - Lymphocyte Signaling

Lyn Antibody #2732

Applications Reactivity MW (kDa) Source
W IP H M R 56 Rabbit

Applications Key:  W=Western Blotting  IP=Immunoprecipitation
Reactivity Key:  H=Human  M=Mouse  R=Rat
Species enclosed in parentheses are predicted to react based on 100% sequence homology. Species cross-reactivity is determined by Western blot.

Specificity / Sensitivity

Lyn Antibody detects endogenous levels of the 56 kDa isoform of Lyn. It does not recognize the 53 kDa Lyn isoform.

Source / Purification

Polyclonal antibodies are produced by immunizing rabbits with a synthetic peptide (KLH-coupled) derived from the amino-terminal sequence of human Lyn. Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from Ramos cells treated with anti-IgM antibody (12 µg/ml for 2 minutes) or untreated, using Lyn Antibody.

Background

Lyn, one of the Src family members, is predominantly expressed in hematopoietic cells (1). Two tyrosine residues have been reported to play a crucial role in the regulation of protein tyrosine kinases of the Src family. Autophosphorylation of Tyr396 (equivalent to Tyr416 of Src), located in the catalytic domain, correlates with enzyme activation. Csk-mediated phosphorylation of the carboxy-terminal Tyr507 (equivalent to Tyr527 of Src) inactivates the kinase. Tyrosine phosphorylation and activation of Lyn occurs upon association with cell surface receptors such as the B cell Ag receptor (BCR) and CD40 (2-4). Studies using knockout mice have shown that the net effect of Lyn deficiency is to render B cells hypersensitive to BCR stimulation (5-7), suggesting that the most critical role for Lyn in vivo is in the down-regulation of B cell responses. Lyn is also involved in controlling the migration and development of specific B cell populations (8).

  1. Yamanashi, Y. et al. (1989) Proc. Natl. Acad. Sci. USA 86, 6538-6542.
  2. Yamanashi, Y. et al. (1991) Science 251, 192-194.
  3. Burkhardt, A.L. et al. (1991) Proc. Natl. Acad. Sci. USA 88, 7410-7414.
  4. Ren, C.L. et al. (1994) J. Exp. Med. 179, 673-680.
  5. Wang, J. et al. (1996) J. Exp. Med. 184, 831-838.
  6. Chan, V.W. et al. (1997) Immunity 7, 69-81.
  7. Hibbs, M. L. et al. (1995) Cell 83, 301-311.
  8. Seo, S.J. et al. (2001) J. Immunol. 166, 3710-3723.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes